Cherisa Meyer

Title: Cherisa Meyer: Innovator in Gene Marker Systems

Introduction

Cherisa Meyer is a prominent inventor based in Ames, IA (US). She has made significant contributions to the field of genetic engineering, particularly in the development of methods for cell identification and isolation.

Latest Patents

Meyer holds a patent for a "Selectable gene marker system based on expression of N-acetyllactosaminide 3-α galactosyltransferase." This innovative method allows for the rapid identification and isolation of cells based on the presence or absence of an ectopically-expressed N-acetyllactosaminide 3-α Galactosyltransferase (αGT) enzyme. The process enables the production of αGalactosyl-(1,3)Galactosyl (αGal) epitopes on the surface of αGal-negative cells. Genetically modified cells expressing the αGT enzyme can be labeled with an antibody composition that recognizes the αGal epitopes, allowing for efficient sorting via fluorescence activated cell sorting (FACS) or magnetic panning techniques. This method is particularly advantageous as it does not require exposing cells to antibiotics.

Career Highlights

Cherisa Meyer is currently associated with Newlink Genetics Corporation, where she continues to advance her research and innovations in genetic engineering. Her work has the potential to impact various applications in biotechnology and medicine.

Collaborations

Meyer collaborates with notable colleagues, including Teresa Di Colandrea and Won-Bin Young, contributing to a dynamic research environment that fosters innovation.

Conclusion

Cherisa Meyer is a trailblazer in the field of genetic engineering, with her patented methods paving the way for advancements in cell identification and isolation. Her contributions are significant in the ongoing evolution of biotechnology.